Company intelligence / Profile preview

Remedy

Dublin, Leinster, Irelandremedygames.com ↗

Ownership: Private
Development stage: Commercial

Overview

Remedy Biologics is an early-stage biotechnology company developing ultra high throughput nano-scale platforms for the rapid discovery of new therapies by analyzing immune function at the single-cell level. Their Nanoreactor™ technology allows multiplexed functional screening and viable recovery of millions to billions of individual cells per sample. The company's primary applications are in immuno-oncology, autoimmune disease, and infectious disease. No clinical results have been published yet as their programs are preclinical/discovery stage.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Cell therapyAntibody
Industry: Biotech

Partnerships

European Innovation Council Fund financingAcademic research teams via its scientific advisory board members' networks

Beyond the preview

Go deeper on Remedy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remedy.

Explore the full profile